NAD+ is marketed as a “fountain of youth” supplement. Here’s what you need to know before you swipe your card.

After being found effective over longer durations with smaller doses, this study found that nipocalimab infusions resulted in a tolerable safety profile and remained effective even in shorter ...

While Eli Lilly’s investigational monoclonal antibody drug, bamlanivimab, just received FDA emergency approval to treat mild coronavirus patients, top officials voiced concerns over its challenging IV ...

People living with early Alzheimer’s disease can now begin treatment with Leqembi without setting foot in an infusion center.

Newborns, particularly premature infants, are highly vulnerable during intravenous infusion treatments due to their low immunity, inability to express discomfort, and fragile veins. Chemical ...

S100-Beta, Melanoma-Inhibiting Activity, and Lactate Dehydrogenase Discriminate Progressive From Nonprogressive American Joint Committee on Cancer Stage IV Melanoma PURPOSE: To evaluate the ...

Medicare covers intravenous (IV) infusion therapy when a doctor prescribes it as medically necessary. Original Medicare Part A typically covers the costs if you have an IV infusion during an inpatient ...

The Alzheimer’s drug Leqembi, the first medicine proven to slow the course of the disease, may be able to be given as a set of two weekly shots at home, a study from drugmaker Eisai suggests, ...

DENVER — Administering multiple intravenous (IV) infusions is common in the critical care environment, but it increases the potential for errors. Researchers with the HumanEra project at University ...

A multi-day intravenous infusion of the local anesthetic lidocaine appears to offer some pain relief to patients battling otherwise untreatable daily migraines. That's the takeaway from a new study ...